Breaking News Instant updates and real-time market news.

DPW

Ault Global Holdings

$5.31 /

+0.33 (+6.63%)

06:34
01/25/21
01/25
06:34
01/25/21
06:34

Ault Global Holdings announces $50M 'at-the-market' equity offering

Ault Global Holdings announced that it has established an "at-the-market" equity offering program under which it may sell, from time to time, shares of its common stock for aggregate gross proceeds of up to $50M. The shares of common stock will be offered through Ascendiant Capital Markets, which will act in its capacity as sales agent. The company intends to use the net proceeds from the "at-the-market" equity offering, if any, for the financing of possible acquisitions of companies and technologies, financing of our emerging electric vehicle charger and energy storage businesses, expansion of our data center business or other business expansions and investments and for working capital and general corporate purposes, which may include the repayment, refinancing, redemption or repurchase of future indebtedness or capital stock. The company does not have agreements or commitments for any specific acquisitions at this time.

TODAY'S FREE FLY STORIES

Earnings
Shift sees Q2 revenue $120M-$130M, consensus $99.73M » 16:43
05/12/21
05/12
16:43
05/12/21
16:43
SFT

Shift

$7.43 /

-0.37 (-4.74%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFT Shift
$7.43 /

-0.37 (-4.74%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

05/04/21 Wedbush
Shift upgraded to Neutral from Underperform at Wedbush
03/09/21 Benchmark
Benchmark sees Shift on a 'positive path,' upgrades to Buy
03/09/21 Benchmark
Shift upgraded to Buy from Hold at Benchmark
01/25/21 DA Davidson
Shift initiated with a Buy at DA Davidson
SFT Shift
$7.43 /

-0.37 (-4.74%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

Earnings
Shift reports Q1 EPS (55c), consensus (44c) » 16:42
05/12/21
05/12
16:42
05/12/21
16:42
SFT

Shift

$7.43 /

-0.37 (-4.74%)

Reports Q1 revenue $106M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFT Shift
$7.43 /

-0.37 (-4.74%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

05/04/21 Wedbush
Shift upgraded to Neutral from Underperform at Wedbush
03/09/21 Benchmark
Benchmark sees Shift on a 'positive path,' upgrades to Buy
03/09/21 Benchmark
Shift upgraded to Buy from Hold at Benchmark
01/25/21 DA Davidson
Shift initiated with a Buy at DA Davidson
SFT Shift
$7.43 /

-0.37 (-4.74%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

SFT Shift
$7.43 /

-0.37 (-4.74%)

Earnings
Bumble raises FY21 revenue view to $724M-$734M from $716M-$726M » 16:40
05/12/21
05/12
16:40
05/12/21
16:40
BMBL

Bumble

$47.13 /

-3.48 (-6.88%)

Consensus $723.9M. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

04/12/21 BTIG
Bumble initiated with a Buy at BTIG
04/12/21 BTIG
Bumble initiated with a Buy at BTIG
04/05/21 Evercore ISI
Bumble initiated with an In Line at Evercore ISI
03/31/21 Wolfe Research
Bumble initiated with a Peer Perform at Wolfe Research
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

  • 11
    Feb
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

BMBL Bumble
$47.13 /

-3.48 (-6.88%)

Earnings
Eyenovia reports Q1 EPS (21c), consensus (22c) » 16:39
05/12/21
05/12
16:39
05/12/21
16:39
EYEN

Eyenovia

$4.57 /

-0.21 (-4.39%)

As of March 31, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EYEN Eyenovia
$4.57 /

-0.21 (-4.39%)

EYEN Eyenovia
$4.57 /

-0.21 (-4.39%)

04/01/21 H.C. Wainwright
Eyenovia price target raised to $8 from $6 at H.C. Wainwright
03/01/21 Northland
Eyenovia initiated with an Outperform at Northland
12/30/20 H.C. Wainwright
H.C. Wainwright reiterates $6 target on Eyenovia after new drug submission
10/23/20 H.C. Wainwright
Eyenovia price target lowered to $6 from $7 at H.C. Wainwright
EYEN Eyenovia
$4.57 /

-0.21 (-4.39%)

  • 19
    Aug
EYEN Eyenovia
$4.57 /

-0.21 (-4.39%)

Earnings
Bumble sees Q2 revenue $175M-$178M, consensus $174.4M » 16:39
05/12/21
05/12
16:39
05/12/21
16:39
BMBL

Bumble

$47.13 /

-3.48 (-6.88%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

04/12/21 BTIG
Bumble initiated with a Buy at BTIG
04/12/21 BTIG
Bumble initiated with a Buy at BTIG
04/05/21 Evercore ISI
Bumble initiated with an In Line at Evercore ISI
03/31/21 Wolfe Research
Bumble initiated with a Peer Perform at Wolfe Research
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

  • 11
    Feb
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

BMBL Bumble
$47.13 /

-3.48 (-6.88%)

Earnings
Bumble reports Q1 EPS $1.69, consensus (4c) » 16:38
05/12/21
05/12
16:38
05/12/21
16:38
BMBL

Bumble

$47.13 /

-3.48 (-6.88%)

Reports Q1 revenue $171M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

04/12/21 BTIG
Bumble initiated with a Buy at BTIG
04/12/21 BTIG
Bumble initiated with a Buy at BTIG
04/05/21 Evercore ISI
Bumble initiated with an In Line at Evercore ISI
03/31/21 Wolfe Research
Bumble initiated with a Peer Perform at Wolfe Research
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

  • 11
    Feb
BMBL Bumble
$47.13 /

-3.48 (-6.88%)

BMBL Bumble
$47.13 /

-3.48 (-6.88%)

Earnings
Cyclacel Pharmaceuticals reports Q1 EPS ($1.48), consensus (49c) » 16:36
05/12/21
05/12
16:36
05/12/21
16:36
CYCC

Cyclacel Pharmaceuticals

$6.38 /

-0.37 (-5.48%)

As of March 31, cash and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYCC Cyclacel Pharmaceuticals
$6.38 /

-0.37 (-5.48%)

CYCC Cyclacel Pharmaceuticals
$6.38 /

-0.37 (-5.48%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 Oppenheimer
Cyclacel Pharmaceuticals initiated with an Outperform at Oppenheimer
04/29/21 Oppenheimer
Cyclacel Pharmaceuticals initiated with an Outperform at Oppenheimer
05/19/20 Brookline
Cyclacel Pharmaceuticals initiated with a Buy at Brookline
  • 12
    Mar
CYCC Cyclacel Pharmaceuticals
$6.38 /

-0.37 (-5.48%)

Earnings
Zosano Pharma reports Q1 EPS (8c), consensus (8c) » 16:35
05/12/21
05/12
16:35
05/12/21
16:35
ZSAN

Zosano Pharma

/

+

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZSAN Zosano Pharma
/

+

ZSAN Zosano Pharma
/

+

03/15/21 Maxim
Zosano Pharma price target raised to $2.50 from $1.50 at Maxim
10/22/20 BTIG
Zosano Pharma price target lowered to $2 from $7 at BTIG
10/02/20 H.C. Wainwright
Zosano Pharma price target lowered to $2.50 from $4 at H.C. Wainwright
09/14/20 BTIG
Satsuma setback a positive for Zosano Pharma, says BTIG
ZSAN Zosano Pharma
/

+

  • 01
    Sep
Earnings
ThredUP sees FY21 revenue $223M-$229M, consensus $211.04M » 16:34
05/12/21
05/12
16:34
05/12/21
16:34
TDUP

ThredUP

$19.95 /

+0.66 (+3.42%)

Sees FY21 gross margin in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

04/20/21 William Blair
ThredUP initiated with an Outperform at William Blair
04/20/21 Wells Fargo
ThredUP initiated with an Overweight at Wells Fargo
04/20/21 Piper Sandler
ThredUP initiated with an Overweight at Piper Sandler
04/20/21 Telsey Advisory
ThredUP initiated with an Outperform at Telsey Advisory
TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

  • 26
    Mar
TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

Earnings
ThredUP sees Q2 revenue $53M-$55M, consensus $48.81M » 16:33
05/12/21
05/12
16:33
05/12/21
16:33
TDUP

ThredUP

$19.95 /

+0.66 (+3.42%)

Sees Q2 gross margin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

04/20/21 William Blair
ThredUP initiated with an Outperform at William Blair
04/20/21 Wells Fargo
ThredUP initiated with an Overweight at Wells Fargo
04/20/21 Piper Sandler
ThredUP initiated with an Overweight at Piper Sandler
04/20/21 Telsey Advisory
ThredUP initiated with an Outperform at Telsey Advisory
TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

  • 26
    Mar
TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

Earnings
Chinook Therapeutics reports Q1 EPS (88c), consensus (68c) » 16:33
05/12/21
05/12
16:33
05/12/21
16:33
KDNY

Chinook Therapeutics

$15.17 /

-0.56 (-3.56%)

Cash Position - Cash,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KDNY Chinook Therapeutics
$15.17 /

-0.56 (-3.56%)

KDNY Chinook Therapeutics
$15.17 /

-0.56 (-3.56%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 Wedbush
Wedbush bullish on Chinook Therapeutics, initiates with an Outperform
KDNY Chinook Therapeutics
$15.17 /

-0.56 (-3.56%)

KDNY Chinook Therapeutics
$15.17 /

-0.56 (-3.56%)

KDNY Chinook Therapeutics
$15.17 /

-0.56 (-3.56%)

Earnings
Knot Offshore Partners reports Q1 revenue $71.5M, two estimates $71.95M » 16:32
05/12/21
05/12
16:32
05/12/21
16:32
KNOP

Knot Offshore Partners

$18.95 /

-0.2 (-1.04%)

Reports Q1 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KNOP Knot Offshore Partners
$18.95 /

-0.2 (-1.04%)

KNOP Knot Offshore Partners
$18.95 /

-0.2 (-1.04%)

03/12/21 B. Riley Securities
Knot Offshore Partners price target raised to $22 from $20 at B. Riley
01/20/21 Barclays
Knot Offshore Partners downgraded to Underweight from Equal Weight at Barclays
01/07/21
Fly Intel: Top five analyst initiations
01/07/21 B. Riley Securities
Knot Offshore Partners initiated with Buy, $20 target at B. Riley
Downgrade
Graybug Vision downgraded to Market Perform from Outperform at SVB Leerink » 16:32
05/12/21
05/12
16:32
05/12/21
16:32
GRAY

Graybug Vision

$4.11 /

-0.66 (-13.84%)

SVB Leerink analyst Marc…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRAY Graybug Vision
$4.11 /

-0.66 (-13.84%)

GRAY Graybug Vision
$4.11 /

-0.66 (-13.84%)

13:37 Today Piper Sandler
Graybug Vision price target lowered to $4 from $10 at Piper Sandler
03/09/21 Wedbush
Wedbush downgrades Graybug Vision to Neutral after data raises questions
03/09/21 Wedbush
Graybug Vision downgraded to Neutral from Outperform at Wedbush
03/09/21 Piper Sandler
Piper downgrades Graybug Vision on efficacy concerns post data
GRAY Graybug Vision
$4.11 /

-0.66 (-13.84%)

  • 25
    Sep
Earnings
ThredUP reports Q1 pro forma EPS (17c), consensus (16c) » 16:32
05/12/21
05/12
16:32
05/12/21
16:32
TDUP

ThredUP

$19.95 /

+0.66 (+3.42%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

04/20/21 William Blair
ThredUP initiated with an Outperform at William Blair
04/20/21 Wells Fargo
ThredUP initiated with an Overweight at Wells Fargo
04/20/21 Piper Sandler
ThredUP initiated with an Overweight at Piper Sandler
04/20/21 Telsey Advisory
ThredUP initiated with an Outperform at Telsey Advisory
  • 26
    Mar
TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

TDUP ThredUP
$19.95 /

+0.66 (+3.42%)

Hot Stocks
Box closes $500M investment led by KKR » 16:31
05/12/21
05/12
16:31
05/12/21
16:31
BOX

Box

$21.94 /

-0.87 (-3.81%)

, KKR

KKR

$54.08 /

-2.19 (-3.89%)

Box (BOX) announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOX Box
$21.94 /

-0.87 (-3.81%)

KKR KKR
$54.08 /

-2.19 (-3.89%)

BOX Box
$21.94 /

-0.87 (-3.81%)

04/09/21 DA Davidson
Box price target lowered to $22 from $25 at DA Davidson
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
KKR KKR
$54.08 /

-2.19 (-3.89%)

05/05/21 Credit Suisse
KKR price target raised to $66 from $60 at Credit Suisse
05/05/21 Deutsche Bank
KKR price target raised to $60 from $52 at Deutsche Bank
04/18/21 BMO Capital
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital
04/14/21 BMO Capital
KKR price target raised to $71 from $69 at BMO Capital
BOX Box
$21.94 /

-0.87 (-3.81%)

KKR KKR
$54.08 /

-2.19 (-3.89%)

  • 11
    Nov
BOX Box
$21.94 /

-0.87 (-3.81%)

KKR KKR
$54.08 /

-2.19 (-3.89%)

BOX Box
$21.94 /

-0.87 (-3.81%)

KKR KKR
$54.08 /

-2.19 (-3.89%)

BOX Box
$21.94 /

-0.87 (-3.81%)

Hot Stocks
Peapack-Gladstone to acquire Princeton Portfolio Strategies Group » 16:31
05/12/21
05/12
16:31
05/12/21
16:31
PGC

Peapack-Gladstone

$31.59 /

-0.2 (-0.63%)

Peapack-Gladstone…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PGC Peapack-Gladstone
$31.59 /

-0.2 (-0.63%)

PGC Peapack-Gladstone
$31.59 /

-0.2 (-0.63%)

04/07/21 Hovde Group
Peapack-Gladstone downgraded to Market Perform from Outperform at Hovde
PGC Peapack-Gladstone
$31.59 /

-0.2 (-0.63%)

Hot Stocks
Penske Automotive appoints Michelle Hulgrave CFO » 16:31
05/12/21
05/12
16:31
05/12/21
16:31
PAG

Penske Automotive

$86.63 /

-2.655 (-2.97%)

Penske Automotive Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAG Penske Automotive
$86.63 /

-2.655 (-2.97%)

PAG Penske Automotive
$86.63 /

-2.655 (-2.97%)

02/11/21 Stephens
Penske Automotive price target raised to $78 from $70 at Stephens
02/10/21 Morgan Stanley
Morgan Stanley cuts Lithia Motors to sell with shares near bull case
01/15/21 Truist
Penske Automotive price target raised to $75 from $65 at Truist
12/07/20 Morgan Stanley
Morgan Stanley upgrades Asbury, downgrades Lithia in auto dealer rating shake-up
PAG Penske Automotive
$86.63 /

-2.655 (-2.97%)

PAG Penske Automotive
$86.63 /

-2.655 (-2.97%)

Earnings
ADMA Biologics reports Q1 EPS (16c), consensus (17c) » 16:30
05/12/21
05/12
16:30
05/12/21
16:30
ADMA

ADMA Biologics

$1.69 /

-0.03 (-1.74%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADMA ADMA Biologics
$1.69 /

-0.03 (-1.74%)

ADMA ADMA Biologics
$1.69 /

-0.03 (-1.74%)

10/01/20 Raymond James
ADMA Biologics price target raised to $9 from $7 at Raymond James
09/30/20 Jefferies
ADMA Biologics shares 'in arbitrage territory,' says Jefferies
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
ADMA ADMA Biologics
$1.69 /

-0.03 (-1.74%)

ADMA ADMA Biologics
$1.69 /

-0.03 (-1.74%)

ADMA ADMA Biologics
$1.69 /

-0.03 (-1.74%)

Options
Preliminary option volume of 41.2M today » 16:30
05/12/21
05/12
16:30
05/12/21
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Ascendis files Phase 3 clinical trial notification for TransCon PTH in Japan » 16:29
05/12/21
05/12
16:29
05/12/21
16:29
ASND

Ascendis Pharma

$137.29 /

+3.33 (+2.49%)

Ascendis Pharma A/S…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$137.29 /

+3.33 (+2.49%)

ASND Ascendis Pharma
$137.29 /

+3.33 (+2.49%)

05/11/21 JPMorgan
Ascendis shares offer 'very compelling entry point,' says JPMorgan
04/13/21 Canaccord
Ascendis Pharma oncology platform remains underappreciated, says Canaccord
03/30/21 Oppenheimer
Ascendis Pharma downgraded to Perform from Outperform at Oppenheimer
03/25/21 JPMorgan
Ascendis 25% selloff brings 'compelling' entry point, says JPMorgan
ASND Ascendis Pharma
$137.29 /

+3.33 (+2.49%)

  • 08
    Jul
Earnings
Custom Truck One Source reports Q1 EPS (57c), consensus (68c) » 16:29
05/12/21
05/12
16:29
05/12/21
16:29
CTOS

Custom Truck One Source

$10.23 /

-0.46 (-4.30%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTOS Custom Truck One Source
$10.23 /

-0.46 (-4.30%)

CTOS Custom Truck One Source
$10.23 /

-0.46 (-4.30%)

04/06/21 Oppenheimer
Custom Truck One Source initiated with an Outperform at Oppenheimer
CTOS Custom Truck One Source
$10.23 /

-0.46 (-4.30%)

Earnings
GoHealth reports Q1 EPS (2c), consensus (1c) » 16:28
05/12/21
05/12
16:28
05/12/21
16:28
GOCO

GoHealth

$11.60 /

-0.285 (-2.40%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$11.60 /

-0.285 (-2.40%)

GOCO GoHealth
$11.60 /

-0.285 (-2.40%)

11/12/20 Evercore ISI
GoHealth price target lowered to $25 from $27 at Evercore ISI
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/02/20 Raymond James
GoHealth initiated with an Outperform at Raymond James
08/14/20 Evercore ISI
GoHealth added to Tactical Outperform List at Evercore ISI
GOCO GoHealth
$11.60 /

-0.285 (-2.40%)

  • 15
    Jul
GOCO GoHealth
$11.60 /

-0.285 (-2.40%)

Earnings
Alto Ingredients reports Q1 EPS 6c, consensus 0c » 16:28
05/12/21
05/12
16:28
05/12/21
16:28
ALTO

Alto Ingredients

$5.31 /

-0.345 (-6.10%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALTO Alto Ingredients
$5.31 /

-0.345 (-6.10%)

ALTO Alto Ingredients
$5.31 /

-0.345 (-6.10%)

ALTO Alto Ingredients
$5.31 /

-0.345 (-6.10%)

ALTO Alto Ingredients
$5.31 /

-0.345 (-6.10%)

Earnings
1Life Healthcare backs FY21 revenue view $465M-$485M, consensus $482.44M » 16:28
05/12/21
05/12
16:28
05/12/21
16:28
ONEM

1Life Healthcare

$38.27 /

-0.49 (-1.26%)

Sees FY21 ending…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

05/03/21 Jefferies
Jefferies confident in path to 'much larger' 1Life Healthcare, starts at Buy
05/03/21 Jefferies
1Life Healthcare initiated with a Buy at Jefferies
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/08/21 Piper Sandler
1Life app downloads suggest Q1 beat, says Piper Sandler
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

Hot Stocks
The Bancorp exec Leto sells nearly 45,000 common shares » 16:27
05/12/21
05/12
16:27
05/12/21
16:27
TBBK

The Bancorp

$22.92 /

-1.71 (-6.94%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TBBK The Bancorp
$22.92 /

-1.71 (-6.94%)

TBBK The Bancorp
$22.92 /

-1.71 (-6.94%)

01/15/21 Piper Sandler
The Bancorp price target raised to $19 from $17 at Piper Sandler
TBBK The Bancorp
$22.92 /

-1.71 (-6.94%)

TBBK The Bancorp
$22.92 /

-1.71 (-6.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.